Our Solutions

April 2018

Altasciences Clinical Research - April 2018 Newsletter
Forward this newsletter | Subscribe
Altasciences Clinical Research - Newsletter
Access Full Newsletter
MEET MARIE-HÉLÈNE RAIGNEAU, General Manager, Altasciences, Canada 5 things private equity firms look for when investing

Scientific Journal

Exclusive access to our latest case study on the safety and tolerability of the world’s first cannabis extract being developed as a drug for regulatory submission.

Bioanalytical Corner and Assay List

Our latest assay list and an overview of our bioanalytical experience with smoking/vaping and inhalation studies.

Industry News

View our latest complimentary webinar to learn about the current strategies used in evaluating the impact of novel tobacco/nicotine products on the health of both users and nonusers.

Press Room

Altasciences' third clinical facility in Fargo, North Dakota, receives its iCardiac/ERT Certification. See all our latest news releases!

Upcoming Events

We’re heading to Amsterdam, Philadelphia and Barcelona… to name a few locations! See the full lineup of events we will be attending and be sure to catch our poster presentations!

» ACCESS FULL NEWSLETTER

 
Forward the newsletter Contact us Subscribe
LinkedIn Twitter Youtube
Algorithme Pharma Clinical Research Vince and Associates Clinical Research Algorithme Pharma USA Clinical Research
© 2018 Altasciences. All Rights Reserved.

THERAPEUTIC AREAS

Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.

Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.

Learn More